Artificial Intelligence in Endoscopic Ultrasound
NCT06564571 is an observational study sponsored by Orlando Health, Inc.. As of 21 Nov 2026, it is recruiting participants. It studies Pancreas Disease, Pancreatic Cancer and 1 more condition. The registry lists an enrollment of 310 participants at 1 site in 1 country. The registry lists a start date of 19 Jan 2024 and a primary completion date of 31 Dec 2026.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT06564571 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | Orlando Health, Inc. |
| Enrollment | 310 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Pancreas Disease, Pancreatic Cancer and Pancreatic Cyst |
| Start | 19 Jan 2024 |
| Primary completion | 31 Dec 2026 |
| Study completion | 31 Dec 2027 |
| Last update posted | 31 May 2025 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shyam Varadarajulu, MD
Orlando Health, Digestive Health Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Orlando Health
Orlando
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT06564571
Each answer restates registry values shown on this page.
What is NCT06564571?
NCT06564571 is an observational study sponsored by Orlando Health, Inc.. It studies Pancreas Disease, Pancreatic Cancer and 1 more condition.
Is NCT06564571 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT06564571?
The registry names Shyam Varadarajulu, MD (principal investigator, Orlando Health, Digestive Health Institute) as the overall official.
Where does NCT06564571 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT06564571 expected to complete?
The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 31 May 2025.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.